HCPLive Network

Perceived Weight Gain Accurate for New Contraceptive Users

 
TUESDAY, Jan. 22 (HealthDay News) -- For new contraceptive users, perceived weight gain, reported by about one-third of users, often represents actual weight gain, according to a study published in the January issue of the American Journal of Obstetrics & Gynecology.

Ashley M. Nault, from the Washington University School of Medicine in St. Louis, and colleagues analyzed self-reported weight change data from 4,133 new contraceptive method users at three, six, and 12 months after enrollment. To assess the validity of self-reported weight gain, data were examined for a subgroup of participants with objective weight measurements at baseline and 12 months.

The researchers found that weight gain was perceived by 34 percent of participants. Implant users and depot medroxyprogesterone acetate users were more likely to report perceived weight gain than copper intrauterine device users (relative risk, 1.29 and 1.37, respectively). There was a mean actual weight gain of 10.3 pounds in women who perceived weight gain. The sensitivity of perceived weight gain was 74.6 percent and the specificity was 84.4 percent.

"In conclusion, self-reported weight change is easy to obtain and in most women represents true weight gain," the authors write. "The perception of weight gain is clinically important because it may affect a woman's satisfaction with her contraceptive method or influence a woman's decision to continue the use of the method."

Two authors disclosed financial ties to the pharmaceutical industry.
 

Abstract
Full Text


Copyright © 2013 HealthDay. All rights reserved.
 
 

Further Reading
Researchers assessed the effect of seizure status and severity, medication use, mental health indicators, parental support, and other factors on self-reported quality of life in children with epilepsy.
A group of international researchers led by Luosheng Li, MD, of the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institutet, Karolinska University Hospital in Stockholm, Sweden, recently demonstrated that age-dependent decline in insulin secretion (and thus glucose homeostasis) from the beta cell in experimental mice models is associated with subtle changes in Ca2+ dynamics.
For patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD), the right treatment can make a world of difference in the management of their condition. A recent study looked at how effective inhaled budesonide and systemic methylprednisolone can be for those patients.
More Reading